Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascimi... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A multi-center, open-label, phase I/II study to evaluate the safety and efficacy of asciminib with ... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy v... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxel... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adj... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant ... Read More
U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738354) titled 'Integrated Prevention, Treatment, and Rehabilitation for Toileting-Related Falls' on July 22... Read More
U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740330) titled 'Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery' on July ... Read More
U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07738939) titled 'IKS04 Regimen in Advanced Solid Tumors That Express CA242' on July 23. Brief Summary: This ... Read More
Singapore, Aug. 1 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the eff... Read More